Page last updated: 2024-08-18

arginine vasopressin and Depression

arginine vasopressin has been researched along with Depression in 41 studies

Research

Studies (41)

TimeframeStudies, this research(%)All Research%
pre-19904 (9.76)18.7374
1990's6 (14.63)18.2507
2000's11 (26.83)29.6817
2010's18 (43.90)24.3611
2020's2 (4.88)2.80

Authors

AuthorsStudies
Chen, X; Dong, C; Guo, T; Li, S; Liu, X; Miao, Y; Ren, T; Ruan, H; Sun, M; Wang, B; Wang, J; Wu, Q; Xin, N; Xu, X; Yang, Y; Yuan, Y; Zhang, HG; Zheng, H; Zuo, Y1
Jungwirth, B; Kagerbauer, SM; Martin, J; Podtschaske, AH; Ulm, B1
Hardin-Pouzet, H; Mhaouty-Kodja, S; Naulé, L1
Balesar, R; Bao, AM; Farajnia, S; Huang, M; Lu, J; Swaab, DF; Wu, X; Zhu, Q1
Hernandez, A; Keyes, LM; López-Espíndola, D; Martinez, ME; Stohn, JP; Zafer, M1
Bangasser, DA; Dalla, C; Hodes, GE; Kokras, N1
Bales, NJ; Borrow, AP; Daniels, RM; Fleury, TK; Handa, RJ; Heck, AL; Miller, AM; Sheng, JA; Stover, SA1
Joca, L; Raber, J; Siegel, JA; Zuloaga, DG1
Carlini, VP; Fiol de Cuneo, M; Kumar, P; Poretti, MB; Rask-Andersen, M; Rubiales de Barioglio, S; Schiöth, HB1
Cai, L; Li, R; Zhou, JN1
Choi, J; Han, PL; Kim, H; Kim, JE; Kim, TK; Lee, EH; Lee, JE; Park, JY1
Nelson, BS; Schank, JR; Sequeira, MK1
Changlani, S; Gueorguieva, R; Gunduz-Bruce, H; Kenney, J; Leone, C; Peixoto, A; Stachenfeld, N1
Brownstein, MJ; Fabio, K; Ferris, CF; Garripa, C; Guillon, C; Heindel, ND; Koppel, GA; Lu, SF; Miller, M; Simon, NG1
de Winter, RF; Goekoop, JG; Spinhoven, P; Wiegant, VM; Wolterbeek, R; Zitman, FG1
Erhardt, A; Holsboer, F; Keck, ME; Mueller, MB; Ohl, F; Sillaber, I; Thoeringer, CK1
Bettecken, T; Bunck, M; Czibere, L; Deussing, JM; Frank, E; Gonik, M; Graf, C; Holsboer, F; Horvath, C; Kessler, MS; Landgraf, R; Muigg, P; Müller-Myhsok, B; Murgatroyd, C; Panhuysen, M; Pütz, B; Singewald, N; Spengler, D; Weber, P1
Almeida, OF; Bockmühl, Y; Fischer, D; Holsboer, F; Micale, V; Murgatroyd, C; Patchev, AV; Spengler, D; Wotjak, CT; Wu, Y1
Lovejoy, DA; Rotzinger, S; Tan, LA1
Bhatnagar, S; Valentino, RJ; Walker, HE; Wood, SK1
de Winter, R; Goekoop, J; Wiegant, V; Wolterbeek, R1
Clarke, G; Cryan, JF; Desbonnet, L; Dinan, TG; Garrett, L; Kiely, B1
Kou, J; Peng, D; Tao, C; Xu, F; Yin, D; Yu, B; Zhu, D1
Hai, GF; Lu, L; Pan, YJ; Wang, DX; Wang, G; Wang, H; Yang, J; Yin, ZK; Zhao, Y1
Landgraf, R1
Cheng, Y; Jiang, Q; Ma, CG; Ming, L; Zhou, LL1
Anisman, H; Merali, Z; Poulter, MO; Prakash, P1
Ando, K; Aoki, M; Asai, M; Ito, Y; Mizuta, K; Nishihori, T1
Gold, PW; Goodwin, FK; Post, RM; Robertson, GL1
Ballenger, JC; Gold, P; Goodwin, FK; Post, RM; Rubinow, DR; Smallberg, SA; Summers, R; Weingartner, H1
Clarke, IJ; Engler, D; Funder, JW; Liu, JP1
Chrousos, GP; Gold, PW; Licinio, J; Wong, ML1
De Wied, D; Goekoop, JG; Lanser, JB; Van Londen, L; Wiegant, VM; Zwinderman, AH1
Dinan, TG; Scott, LV1
Gold, PW; Michelson, D1
Hamanaka, K; Kitayama, I; Nakase, S; Nomura, J; Soya, H1
Hofman, MA; Hoogendijk, WJ; Kamphorst, W; Liu, RY; Swaab, DF; Unmehopa, UA; van Heerikhuize, J; Zhou, JN1
Ekman, R; Gobom, J; Mecocci, P; Nilsson, CL; Persson, R1
Donald, RA; Inder, WJ; Joyce, PR; Mulder, RT; Prickett, TC1
Orenstein, H; Raskind, M; Weitzman, RE1
Ballenger, JC; Gold, PW; Goodwin, FK; Post, RM; Weingartner, H1

Reviews

5 review(s) available for arginine vasopressin and Depression

ArticleYear
Sex differences in the hypothalamic-pituitary-adrenal axis: An obstacle to antidepressant drug development?
    British journal of pharmacology, 2019, Volume: 176, Issue:21

    Topics: Animals; Antidepressive Agents; Arginine Vasopressin; Corticotropin-Releasing Hormone; Depression; Drug Development; Humans; Hypothalamo-Hypophyseal System; Pituitary-Adrenal System; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Sex Characteristics

2019
Vasopressin antagonists as anxiolytics and antidepressants: recent developments.
    Recent patents on CNS drug discovery, 2008, Volume: 3, Issue:2

    Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Arginine Vasopressin; Depression; Humans; Hypothalamo-Hypophyseal System; Pituitary-Adrenal System; Vasopressins

2008
Behavioral effects of neuropeptides in rodent models of depression and anxiety.
    Peptides, 2010, Volume: 31, Issue:4

    Topics: Animals; Anxiety; Arginine Vasopressin; Behavior, Animal; Cholecystokinin; Corticotropin-Releasing Hormone; Depression; Disease Models, Animal; Galanin; Humans; MSH Release-Inhibiting Hormone; Neuropeptide Y; Neuropeptides; Neuropsychological Tests; Oxytocin; Social Behavior; Urocortins

2010
Corticotropin releasing hormone in the pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs.
    Annals of the New York Academy of Sciences, 1995, Dec-29, Volume: 771

    Topics: Adrenocorticotropic Hormone; Antidepressive Agents; Arginine Vasopressin; Corticotropin-Releasing Hormone; Cushing Syndrome; Depression; Depressive Disorder; Fatigue; Fatigue Syndrome, Chronic; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Pituitary-Adrenal System; Seasonal Affective Disorder

1995
Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: implications for the pathophysiology of depression.
    Life sciences, 1998, Volume: 62, Issue:22

    Topics: Adrenocorticotropic Hormone; Animals; Arginine Vasopressin; Corticotropin-Releasing Hormone; Depression; Humans; Hypothalamo-Hypophyseal System; Pituitary-Adrenal System; Signal Transduction

1998

Trials

2 trial(s) available for arginine vasopressin and Depression

ArticleYear
Reduction in basal afternoon plasma ACTH during early treatment of depression with fluoxetine.
    Psychopharmacology, 2001, Volume: 156, Issue:1

    Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Analysis of Variance; Arginine Vasopressin; Depression; Female; Fluoxetine; Humans; Hydrocortisone; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Statistics, Nonparametric

2001
Effects of 1-desamo-8-D-arginine vasopressin on behaviour and cognition in primary affective disorder.
    Lancet (London, England), 1979, Nov-10, Volume: 2, Issue:8150

    Topics: Affective Symptoms; Arginine Vasopressin; Cognition; Deamino Arginine Vasopressin; Depression; Evaluation Studies as Topic; Humans; Male; Memory, Short-Term

1979

Other Studies

34 other study(ies) available for arginine vasopressin and Depression

ArticleYear
Depression compromises antiviral innate immunity via the AVP-AHI1-Tyk2 axis.
    Cell research, 2022, Volume: 32, Issue:10

    Topics: Adaptor Proteins, Vesicular Transport; Animals; Antiviral Agents; Arginine Vasopressin; Depression; Depressive Disorder, Major; Immunity, Innate; Interferons; Leukocytes, Mononuclear; Meptazinol; Mice

2022
Influence of perioperative stress on central and peripheral oxytocin and arginine-vasopressin concentrations.
    Journal of neuroendocrinology, 2019, Volume: 31, Issue:10

    Topics: Aged; Aged, 80 and over; Anxiety; Arginine Vasopressin; Depression; Female; Humans; Male; Middle Aged; Oxytocin; Perioperative Period; Pilot Projects; Saliva; Self Report; Stress, Psychological; Time Factors

2019
[Estrogens and social and emotional related behaviors: Role of estrogen receptor β].
    Medecine sciences : M/S, 2021, Volume: 37, Issue:2

    Topics: Age Factors; Animals; Arginine Vasopressin; Behavior, Animal; Depression; Emotional Regulation; Estrogen Receptor beta; Female; Hypothalamus; Male; Mice; Mutation; Neurons; Oxytocin; Sex Factors; Social Behavior; Testosterone; Tryptophan Hydroxylase

2021
Increased glutamic acid decarboxylase expression in the hypothalamic suprachiasmatic nucleus in depression.
    Brain structure & function, 2017, Volume: 222, Issue:9

    Topics: Aged; Aged, 80 and over; Arginine Vasopressin; Depression; Female; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Humans; Male; RNA, Messenger; Sex Factors; Statistics, Nonparametric; Suprachiasmatic Nucleus

2017
Increased aggression and lack of maternal behavior in Dio3-deficient mice are associated with abnormalities in oxytocin and vasopressin systems.
    Genes, brain, and behavior, 2018, Volume: 17, Issue:1

    Topics: Aggression; Animals; Anxiety; Arginine Vasopressin; Behavior, Animal; Brain; Depression; Female; Hypothalamus; Iodide Peroxidase; Male; Maternal Behavior; Mice; Mice, Inbred C57BL; Oxytocin; Social Behavior

2018
Chronic variable stress alters hypothalamic-pituitary-adrenal axis function in the female mouse.
    Physiology & behavior, 2019, 10-01, Volume: 209

    Topics: Animals; Anxiety; Arginine Vasopressin; Chronic Disease; Corticotropin-Releasing Hormone; Depression; Female; Gene Expression Regulation; Glucocorticoids; Hypothalamo-Hypophyseal System; Mice; Mice, Inbred C57BL; Oxytocin; Paraventricular Hypothalamic Nucleus; Pituitary-Adrenal System; Restraint, Physical; Stress, Psychological

2019
Long-term effects of early adolescent methamphetamine exposure on depression-like behavior and the hypothalamic vasopressin system in mice.
    Developmental neuroscience, 2014, Volume: 36, Issue:2

    Topics: Animals; Animals, Newborn; Arginine Vasopressin; Behavior, Animal; Cognition; Depression; Female; Humans; Hypothalamo-Hypophyseal System; Male; Methamphetamine; Mice, Inbred C57BL; Paraventricular Hypothalamic Nucleus; Pituitary-Adrenal System; Sex Characteristics; Time; Vasopressins

2014
Ghrelin effects expression of several genes associated with depression-like behavior.
    Progress in neuro-psychopharmacology & biological psychiatry, 2015, Jan-02, Volume: 56

    Topics: Adrenocorticotropic Hormone; Analysis of Variance; Animals; Antidepressive Agents; Arginine Vasopressin; Corticotropin-Releasing Hormone; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Gene Expression Regulation; Ghrelin; Interleukin-1beta; Mice; Olfactory Bulb; Receptors, LH; Receptors, Opioid; Serotonin Plasma Membrane Transport Proteins

2015
Chronic all-trans retinoic acid administration induces CRF over-expression accompanied by AVP up-regulation and multiple CRF-controlling receptors disturbance in the hypothalamus of rats.
    Brain research, 2015, Mar-19, Volume: 1601

    Topics: Animals; Arginine Vasopressin; Corticosterone; Corticotropin-Releasing Hormone; Depression; Disease Models, Animal; Estrogen Receptor beta; Gene Expression; Hypothalamus; Male; Motor Activity; Neurons; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Receptors, Mineralocorticoid; RNA, Messenger; Tretinoin

2015
G9a-Mediated Regulation of OXT and AVP Expression in the Basolateral Amygdala Mediates Stress-Induced Lasting Behavioral Depression and Its Reversal by Exercise.
    Molecular neurobiology, 2016, Volume: 53, Issue:5

    Topics: Animals; Arginine Vasopressin; Basolateral Nuclear Complex; Behavior, Animal; Depression; Histone-Lysine N-Methyltransferase; Male; Mice, Inbred C57BL; Oxytocin; Physical Conditioning, Animal; Receptors, Oxytocin; Receptors, Vasopressin; RNA, Small Interfering; Stress, Psychological; Transcription, Genetic; Up-Regulation

2016
Bidirectional relationship between alcohol intake and sensitivity to social defeat: association with Tacr1 and Avp expression.
    Addiction biology, 2018, Volume: 23, Issue:1

    Topics: Alcohol Drinking; Alcoholism; Animals; Arginine Vasopressin; Behavior, Animal; Brain; Depression; Epigenesis, Genetic; Genetic Predisposition to Disease; Interpersonal Relations; Male; Mice; Receptors, Neurokinin-1; Resilience, Psychological; RNA, Messenger; Social Behavior; Stress, Psychological

2018
A translational approach for NMDA receptor profiling as a vulnerability biomarker for depression and schizophrenia.
    Experimental physiology, 2017, 05-01, Volume: 102, Issue:5

    Topics: Adult; Arginine Vasopressin; Biomarkers; Depression; Female; Humans; Male; Osmolar Concentration; Receptors, N-Methyl-D-Aspartate; Saline Solution, Hypertonic; Schizophrenia; Water-Electrolyte Balance

2017
Reduced cooperativeness and reward-dependence in depression with above-normal plasma vasopressin concentration.
    Journal of psychopharmacology (Oxford, England), 2009, Volume: 23, Issue:8

    Topics: Adult; Arginine Vasopressin; Cooperative Behavior; Depression; Female; Humans; Male; Middle Aged; Reward

2009
Long-term anxiolytic and antidepressant-like behavioural effects of tiagabine, a selective GABA transporter-1 (GAT-1) inhibitor, coincide with a decrease in HPA system activity in C57BL/6 mice.
    Journal of psychopharmacology (Oxford, England), 2010, Volume: 24, Issue:5

    Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Arginine Vasopressin; Corticosterone; Corticotropin-Releasing Hormone; Depression; GABA Agonists; GABA Plasma Membrane Transport Proteins; GABA Uptake Inhibitors; Gene Expression Regulation; Hippocampus; Hypothalamo-Hypophyseal System; Male; Mice; Mice, Inbred C57BL; Nipecotic Acids; Paraventricular Hypothalamic Nucleus; Pituitary-Adrenal System; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Receptors, Steroid; RNA, Messenger; Tiagabine

2010
A hypomorphic vasopressin allele prevents anxiety-related behavior.
    PloS one, 2009, Volume: 4, Issue:4

    Topics: Alleles; Animals; Anxiety; Arginine Vasopressin; Behavior, Animal; Depression; Female; Gene Expression Profiling; Humans; Male; Mice; Motor Activity; Neuropsychological Tests; Oligonucleotide Array Sequence Analysis; Oxytocin; Paraventricular Hypothalamic Nucleus; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Supraoptic Nucleus

2009
Dynamic DNA methylation programs persistent adverse effects of early-life stress.
    Nature neuroscience, 2009, Volume: 12, Issue:12

    Topics: Animals; Animals, Newborn; Arginine Vasopressin; Behavior, Animal; Corticosterone; Depression; DNA Methylation; Enhancer Elements, Genetic; Epigenesis, Genetic; Hypothalamo-Hypophyseal System; Methyl-CpG-Binding Protein 2; Mice; Neurons; Paraventricular Hypothalamic Nucleus; Phenotype; Phosphorylation; Stress, Physiological; Transcription, Genetic

2009
Individual differences in reactivity to social stress predict susceptibility and resilience to a depressive phenotype: role of corticotropin-releasing factor.
    Endocrinology, 2010, Volume: 151, Issue:4

    Topics: Adrenocorticotropic Hormone; Analysis of Variance; Animals; Arginine Vasopressin; Behavior, Animal; Body Weight; Cluster Analysis; Corticotropin-Releasing Hormone; Depression; Dominance-Subordination; Hypothalamo-Hypophyseal System; In Situ Hybridization; Individuality; Male; Paraventricular Hypothalamic Nucleus; Pituitary Gland; Pituitary-Adrenal System; Proto-Oncogene Proteins c-fos; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Restraint, Physical; RNA, Messenger; Stress, Physiological; Stress, Psychological; Time Factors

2010
Support for two increased vasopressinergic activities in depression at large and the differential effect of antidepressant treatment.
    Journal of psychopharmacology (Oxford, England), 2011, Volume: 25, Issue:10

    Topics: Adult; Antidepressive Agents; Arginine Vasopressin; Depression; Female; Humans; Hydrocortisone; Male; Middle Aged; Receptors, Vasopressin

2011
Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression.
    Neuroscience, 2010, Nov-10, Volume: 170, Issue:4

    Topics: Animals; Antidepressive Agents; Arginine Vasopressin; Behavior, Animal; Bifidobacterium; Biogenic Monoamines; Brain; Citalopram; Concanavalin A; Corticosterone; Corticotropin-Releasing Hormone; Cytokines; Depression; Disease Models, Animal; Female; Lipopolysaccharides; Maternal Deprivation; Probiotics; Rats; Rats, Sprague-Dawley; RNA, Messenger; Stress, Psychological; Tryptophan

2010
Anti-depression effects of Danggui-Shaoyao-San, a fixed combination of Traditional Chinese Medicine, on depression model in mice and rats.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2011, Oct-15, Volume: 18, Issue:13

    Topics: Animals; Antidepressive Agents; Arginine Vasopressin; Behavior, Animal; Depression; Disease Models, Animal; Drugs, Chinese Herbal; Humans; Male; Mice; Phytotherapy; Pituitary Gland; Plants, Medicinal; Rats; Rats, Sprague-Dawley; RNA, Messenger; Swimming

2011
Effect of arginine vasopressin on the behavioral activity in the behavior despair depression rat model.
    Neuropeptides, 2012, Volume: 46, Issue:3

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Behavior, Animal; Depression; Helplessness, Learned; Hindlimb Suspension; Injections, Intravenous; Injections, Intraventricular; Male; Pituitary Gland; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Spinal Cord; Swimming

2012
[Neurobiology and genetics of anxiety in an animal model].
    Der Nervenarzt, 2003, Volume: 74, Issue:3

    Topics: Animals; Antidepressive Agents, Second-Generation; Anxiety; Arginine Vasopressin; Arousal; Corticotropin-Releasing Hormone; Depression; Dexamethasone; Disease Models, Animal; Hypothalamo-Hypophyseal System; Motor Activity; Paroxetine; Phenotype; Pituitary-Adrenal System; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Rats; Rats, Inbred Strains; Receptors, Vasopressin

2003
Antidepressant-like effects of BCEF0083 in the chronic unpredictable stress models in mice.
    Chinese medical journal, 2005, Jun-05, Volume: 118, Issue:11

    Topics: Animals; Antidepressive Agents; Arginine Vasopressin; Body Weight; Chronic Disease; Depression; Disease Models, Animal; Escape Reaction; Fungi; Male; Mice; Reward

2005
Corticotropin releasing hormone receptor alterations elicited by acute and chronic unpredictable stressor challenges in stressor-susceptible and resilient strains of mice.
    Behavioural brain research, 2007, Aug-06, Volume: 181, Issue:2

    Topics: Analysis of Variance; Animals; Anxiety; Arginine Vasopressin; Corticotropin-Releasing Hormone; Depression; Disease Models, Animal; Frontal Lobe; Immunohistochemistry; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Random Allocation; Receptors, Corticotropin-Releasing Hormone; RNA, Messenger; Species Specificity; Stress, Psychological; Tissue Distribution

2007
The relevance of an elevation in the plasma vasopressin levels to the pathogenesis of Meniere's attack.
    Journal of neuroendocrinology, 2007, Volume: 19, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Arginine Vasopressin; Depression; Female; Humans; Male; Meniere Disease; Middle Aged; Osmolar Concentration; Plasma; Quality of Life; Retrospective Studies; Statistics as Topic; Surveys and Questionnaires; Vertigo

2007
Vasopressin function in depression and mania [proceedings].
    Psychopharmacology bulletin, 1981, Volume: 17, Issue:1

    Topics: Affective Disorders, Psychotic; Anxiety; Arginine Vasopressin; Bipolar Disorder; Cognition; Depression; Humans; Psychotic Disorders; Saline Solution, Hypertonic

1981
Effects of vasopressin on human memory functions.
    Science (New York, N.Y.), 1981, Feb-06, Volume: 211, Issue:4482

    Topics: Adult; Arginine Vasopressin; Cognition; Deamino Arginine Vasopressin; Depression; Female; Humans; Learning; Male; Memory; Middle Aged

1981
Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. II. The central noradrenergic and neuropeptide Y pathways cause immediate and prolonged hypothalamic-pituit
    The Journal of clinical investigation, 1994, Volume: 93, Issue:4

    Topics: Animals; Anorexia Nervosa; Arginine Vasopressin; Corticotropin-Releasing Hormone; Cushing Syndrome; Depression; Female; Hypothalamo-Hypophyseal System; Neuropeptide Y; Norepinephrine; Pituitary-Adrenal System; Sheep; Sodium Chloride

1994
Neuropsychological performance and plasma cortisol, arginine vasopressin and oxytocin in patients with major depression.
    Psychological medicine, 1998, Volume: 28, Issue:2

    Topics: Adult; Aged; Analysis of Variance; Arginine Vasopressin; Attention; Chi-Square Distribution; Cognition; Cohort Studies; Depression; Depressive Disorder; Female; Humans; Hydrocortisone; Male; Memory; Middle Aged; Neuropsychological Tests; Oxytocin; Severity of Illness Index; Verbal Learning; Wechsler Scales

1998
Pathophysiologic and somatic investigations of hypothalamic-pituitary-adrenal axis activation in patients with depression.
    Annals of the New York Academy of Sciences, 1998, May-01, Volume: 840

    Topics: Adrenocorticotropic Hormone; Arginine Vasopressin; Bone Density; Depression; Female; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Multiple Sclerosis; Pituitary-Adrenal System

1998
Increased expression of magnocellular arginine vasopressin mRNA in paraventricular nucleus of stress-induced depression-model rats.
    Life sciences, 1998, Volume: 63, Issue:1

    Topics: Adrenocorticotropic Hormone; Animals; Arginine Vasopressin; Corticotropin-Releasing Hormone; Depression; Disease Models, Animal; Male; Paraventricular Hypothalamic Nucleus; Rats; Rats, Wistar; RNA, Messenger; Stress, Physiological

1998
Decreased vasopressin gene expression in the biological clock of Alzheimer disease patients with and without depression.
    Journal of neuropathology and experimental neurology, 2000, Volume: 59, Issue:4

    Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Arginine Vasopressin; Circadian Rhythm; Depression; Female; Gene Expression; Humans; In Situ Hybridization; Male; Middle Aged; RNA, Messenger; Severity of Illness Index; Suprachiasmatic Nucleus

2000
Arginine vasopressin in the cytoplasm and nuclear fraction of lymphocytes from healthy donors and patients with depression or schizophrenia.
    Peptides, 2001, Volume: 22, Issue:1

    Topics: Adult; Aged; Arginine Vasopressin; Blood Donors; Cell Nucleus; Cytoplasm; Depression; Humans; Lymphocytes; Middle Aged; Schizophrenia

2001
Vasopressin in depression.
    Lancet (London, England), 1979, Jan-20, Volume: 1, Issue:8108

    Topics: Arginine Vasopressin; Depression; Electroconvulsive Therapy; Female; Follow-Up Studies; Humans; Middle Aged

1979